Close

Erickson Joins BIO as Director for New Industrial and Environmental Biotechnology Section

WASHINGTON, D.C. (March 22, 2000) -- BIO announced today that Brent Erickson has been named director of the newly created Industrial and Environmental Biotechnology Section. Industrial...

Major Study Of Biotech Research On Age-Related Diseases To Be Released At BIO 2000

WASHINGTON, DC (March 23, 2000) The Alliance for Aging Research will release the first ever profile of biotechnology companies focusing on age-related diseases and offer recommendations for...

BIO 2000 Program Provides Teachers Update On Biotechnology

WASHINGTON, D.C. (March 23, 2000) More than 100 teachers from 23 states and Canada will take part in the Teacher Professional Development Program at BIO 2000, March 26-30, in Boston.

The three...

BIO Files Comments On Proposed Guidelines From PTO For Patenting Gene-Based Inventions

WASHINGTON, D.C. (March 22, 2000) The Biotechnology Industry Organization (BIO) today filed comments with the U.S. Patent and Trademark Office (PTO) on its proposed guidelines and training manual...

People Battling Illnesses, Injuries Discuss Personal Experiences At BIO 2000

WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis and Gaucher disease will discuss their...

BIO 2000 Speakers Discuss Human Genome Project, Agricultural Biotech In Developing Nations

WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and benefits of agricultural biotechnology in...

Backgrounder On Patenting Gene-Based Inventions

...

BIO 2000 Attracts Record International Contingent

Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual conference of the Biotechnology Industry...

BIO Responds To Clinton, Blair Statement On Gene-Based Health-Care Research

WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill Clinton and British Prime Minister Tony...

Testimony of Michael J. Werner, Esq.

On behalf of the Biotechnology Industry Organization (BIO), regarding the Proposal That Calls For A Moratorium on Some Human Gene Therapy Protocols before the NIH Recombinant DNA Advisory Committee.